Nihon Kohden Operating Income 2015-2025 | NHNKY
Nihon Kohden operating income from 2015 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Nihon Kohden Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $137 |
| 2024 | $135 |
| 2023 | $156 |
| 2022 | $276 |
| 2021 | $244 |
| 2020 | $143 |
| 2019 | $135 |
| 2018 | $131 |
| 2017 | $121 |
| 2016 | $146 |
| 2015 | $132 |
| 2014 | $171 |
| Nihon Kohden Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $10 |
| 2024-12-31 | |
| 2024-06-30 | $-8 |
| 2023-06-30 | $16 |
| 2022-06-30 | $14 |
| 2021-06-30 | $58 |
| 2020-06-30 | $17 |
| 2019-06-30 | $5 |
| 2018-06-30 | $0 |
| 2017-06-30 | $-2 |
| 2016-06-30 | $-4 |
| 2015-06-30 | $1 |
| 2014-06-30 | $10 |
| 2014-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.992B | $1.480B |
| Nihon Kohden Corporation is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company offers electroencephalograph, electromyography, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.057B | 22.51 |
| Intuitive Surgical (ISRG) | United States | $169.665B | 70.33 |
| IDEXX Laboratories (IDXX) | United States | $51.770B | 53.88 |
| Edwards Lifesciences (EW) | United States | $47.755B | 31.65 |
| Alcon (ALC) | Switzerland | $39.366B | 26.43 |
| IQVIA Holdings (IQV) | United States | $32.438B | 18.33 |
| DexCom (DXCM) | United States | $29.545B | 44.32 |
| Mettler-Toledo (MTD) | United States | $26.800B | 31.81 |
| STERIS (STE) | Ireland | $24.136B | 25.69 |
| Waters (WAT) | United States | $17.964B | 24.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
| Hologic (HOLX) | United States | $14.929B | 16.17 |
| Penumbra (PEN) | United States | $10.633B | 77.68 |
| Globus Medical (GMED) | United States | $8.275B | 19.09 |
| Sysmex ADR (SSMXY) | Japan | $7.913B | 25.14 |
| Masimo (MASI) | United States | $7.590B | 25.54 |
| Teleflex (TFX) | United States | $5.586B | 9.02 |
| Glaukos (GKOS) | United States | $5.495B | 0.00 |
| TransMedics (TMDX) | United States | $3.919B | 59.56 |
| Integer Holdings (ITGR) | United States | $3.779B | 18.86 |
| LivaNova (LIVN) | United Kingdom | $3.078B | 17.62 |
| Veracyte (VCYT) | United States | $2.387B | 32.98 |
| Alphatec Holdings (ATEC) | United States | $2.353B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.235B | 0.00 |
| Artivion (AORT) | United States | $2.073B | 104.60 |
| Elekta AB (EKTAY) | Sweden | $1.815B | 17.59 |
| Integra LifeSciences Holdings (IART) | United States | $1.179B | 6.75 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.046B | 0.00 |
| IRadimed (IRMD) | United States | $0.921B | 44.72 |
| Tandem Diabetes Care (TNDM) | United States | $0.845B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.819B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.719B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.554B | 9.79 |
| OrthoPediatrics (KIDS) | United States | $0.536B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.439B | 3.52 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.385B | 91.83 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.48 |
| RxSight (RXST) | United States | $0.370B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.309B | 0.00 |
| NeuroPace (NPCE) | United States | $0.303B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.297B | 20.48 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.236B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| CVRx (CVRX) | United States | $0.205B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.107B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.60 |